Published: 03rd Sep 2024
By: Value Research
Indian chemical manufacturers are facing stiff competition from cheap Chinese products and a tough economic climate. Amidst these threats, one small-cap company is defying the odds.
Despite the headwinds, Anupam Rasayan is thriving. It has maintained a robust median operating profit margin of 20 per cent in the past five years. How? We will discuss this in the following slides.
To minimise the impact of cheap Chinese imports, Anupam Rasayan has focussed on high-quality, custom synthesis of agrochemicals tailored to the specific needs of its clients.
Anupam Rasayan ventured into fluorine-based chemicals but initially faced setbacks due to raw material shortages. In 2022, it acquired Tanfac, a key raw material producer. This enabled it to become the only Asian manufacturer of certain fluorine-based products.
Looking ahead, Anupam Rasayan plans to supply fluorine-based products to pharma companies. Tapping into the market worth over $15 billion would promise substantial future growth.
While Anupam Rasayan promises a smooth growth trajectory, there are potential bumps ahead. To learn more about these risks, click below to read the full story: